COMPUESTOS MEJORADOS FARMACOCINETICAMENTE

Se proporciona un compuesto de la formula A que tiene caracteristicas de union no especifica y propiedades farmacocineticas mejoradas, o una sal farmaceuticamente aceptable, un estereoisomero o hidrato de el, en donde R1 es alquilo inferior, R2 y R3 se seleccionan independientemente de alquilo infer...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: DAVID DUFFY, EMANUELE OSTUNI, PAUL SWEETNAM, MICHAEL GORGAN, STEVEN KATES, STEWART CAMPBELL
Format: Patent
Sprache:spa
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Se proporciona un compuesto de la formula A que tiene caracteristicas de union no especifica y propiedades farmacocineticas mejoradas, o una sal farmaceuticamente aceptable, un estereoisomero o hidrato de el, en donde R1 es alquilo inferior, R2 y R3 se seleccionan independientemente de alquilo inferior, y alquenilo inferior y alquinilo inferior. A compound of formula A having improved non-specific binding characteristics and pharmacokinetic properties is provided: or pharmaceutically acceptable salt, stereoisomer, or hydrate thereof, wherein R1 is lower alkyl, R2 and R3 are independently selected from lower alkyl, and lower alkenyl and lower alkynyl, wherein the lower alkyl, lower alkenyl, and lower alkynyl may be optionally substituted with one or more halogen, lower alkoxy, hydroxy, CN, NO2, amino, acylamino, amido, carbonyl, and alkylthio, A is N or C-H, B is N, C-H, C-(SO2-R4), or C-CO-R4, D is N, C-H, C-(SO2-R4) or C-CO-R4, E is N or C-H, wherein only one of A, B or E may be N, and one of B or D is C-(SO2-R4) or C-CO-R4, R4 is a group having the formula: in which each R5, R6, R7 and R8 are independently selected from H and lower alkyl, wherein the lower alkyl may be optionally substituted with one or more halogen, lower alkoxy, hydroxy, CN, NO2, amino, acylamino, amido, carbonyl, and alkylthio; and additionally or alternatively R6 and R5 together form a 5- or 6-membered ring, or R6 and R7 together form a 3 to 6 membered ring; R9 is independently selected from H and lower alkyl, wherein the lower alkyl may be optionally substituted with one or more halogen, lower alkoxy, hydroxy, CN, NO2, amino, acylamino, amido, carbonyl, and alkylthio; alternatively R8 and R9 together with the nitrogen to which they are attached form a 5- or 6-membered ring; n is 1 to 4; and m is 1 to 6.